
Results
189
Companies which are potentially undervalued and in an acceptable financial position.
189 companies
High Tide
Market Cap: CA$273.3m
Engages in the cannabis retail business in Canada, the United States, and internationally.
HITI
CA$3.04
7D
-0.7%
1Y
-6.7%
Trulieve Cannabis
Market Cap: US$1.7b
Operates as a cannabis retailer in the United States.
TRLV
US$8.67
7D
0.5%
1Y
95.3%
CorMedix
Market Cap: US$610.4m
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
CRMD
US$8.19
7D
-1.0%
1Y
-25.9%
Hypera
Market Cap: R$14.2b
Operates as a pharmaceutical company in Brazil.
HYPE3
R$20.24
7D
-3.5%
1Y
-23.6%
Innovent Biologics
Market Cap: HK$160.6b
A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally.
1801
HK$92.25
7D
-4.9%
1Y
4.8%
Zhejiang Jiuzhou Pharmaceutical
Market Cap: CN¥13.4b
Operates as contract development and manufacturing organization (CDMO) company in China and internationally.
603456
CN¥15.17
7D
-4.5%
1Y
-9.1%
Sanofi
Market Cap: €92.3b
Engages in the research, development, manufacture, and marketing of therapeutic solutions.
SAN
€76.84
7D
0.8%
1Y
-9.2%
3SBio
Market Cap: HK$43.2b
An investment holding company, engages in the development, production, marketing, and sale of biopharmaceutical products in the People’s Republic of China, the United States, and internationally.
1530
HK$17.29
7D
-4.7%
1Y
-39.4%
Regeneron Pharmaceuticals
Market Cap: US$68.7b
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide.
REGN
US$651.18
7D
-2.0%
1Y
13.8%
Arcutis Biotherapeutics
Market Cap: US$3.5b
A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
ARQT
US$27.90
7D
0.4%
1Y
87.1%
Supernus Pharmaceuticals
Market Cap: US$2.8b
A biopharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States.
SUPN
US$47.87
7D
2.6%
1Y
46.5%
Hugel
Market Cap: ₩2.4t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩221,500.00
7D
-5.1%
1Y
-37.0%
Dong-A Socio Holdings
Market Cap: ₩510.4b
Engages in the pharmaceutical business in South Korea.
A000640
₩77,000.00
7D
-5.5%
1Y
-34.8%
Yunnan Baiyao GroupLtd
Market Cap: CN¥92.3b
Engages in the sale of pharmaceuticals, medicinal materials, health and daily chemical products in China.
000538
CN¥51.75
7D
1.9%
1Y
-8.5%
Vetoquinol
Market Cap: €834.5m
A veterinary pharmaceutical company, engages in designing, developing, and selling of veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region.
VETO
€71.70
7D
-1.2%
1Y
-6.4%
Ardelyx
Market Cap: US$1.3b
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
ARDX
US$5.09
7D
-1.4%
1Y
15.0%
Dong-E-E-Jiao
Market Cap: CN¥32.8b
Engages in the research, development, production, and sale of donkey-hide gelatin and related products in China and internationally.
000423
CN¥51.44
7D
2.8%
1Y
0.9%
Bavarian Nordic
Market Cap: DKK 13.8b
Develops, manufactures, and supplies life-saving vaccines.
BAVA
DKK 180.10
7D
-2.1%
1Y
-6.4%
Fine Foods & Pharmaceuticals N.T.M
Market Cap: €203.7m
Fine Foods & Pharmaceuticals N.T.M. S.p.A.
FF
€8.64
7D
-4.8%
1Y
8.8%
Diaceutics
Market Cap: UK£112.2m
A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.
DXRX
UK£1.32
7D
-2.6%
1Y
1.5%
Dong-A ST
Market Cap: ₩331.6b
Develops, manufactures, and markets pharmaceutical products in South Korea and internationally.
A170900
₩34,400.00
7D
-4.2%
1Y
-27.9%
Duopharma Biotech Berhad
Market Cap: RM 1.2b
Researches, develops, manufactures, markets, sells, imports, and distributes pharmaceutical products and medicines in Malaysia and internationally.
DPHARMA
RM 1.24
7D
2.5%
1Y
-10.1%
Amoy Diagnostics
Market Cap: CN¥6.8b
Engages in research and development, production, sale, and supporting services of tumor precision medical diagnostic products in China and internationally.
300685
CN¥17.53
7D
-5.6%
1Y
-25.9%
Decibel Cannabis
Market Cap: CA$60.6m
An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.
DB
CA$0.11
7D
-4.3%
1Y
15.8%
Journey Medical
Market Cap: US$201.3m
A commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
DERM
US$7.12
7D
-2.1%
1Y
-3.7%
Fennec Pharmaceuticals
Market Cap: US$360.9m
Operates as a commercial stage biopharmaceutical company in the United States.
FENC
US$10.32
7D
-2.6%
1Y
18.2%
Exagen
Market Cap: US$113.1m
Designs, develops, and commercializes various testing products under the AVISE brand in the United States.
XGN
US$4.86
7D
18.8%
1Y
-30.0%
China Resources Pharmaceutical Group
Market Cap: HK$30.0b
An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.
3320
HK$4.78
7D
3.0%
1Y
-13.4%
Dermapharm Holding
Market Cap: €2.1b
Manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China.
DMP
€40.30
7D
-7.4%
1Y
16.6%
United Laboratories International Holdings
Market Cap: HK$18.2b
An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.
3933
HK$9.22
7D
-0.1%
1Y
-42.9%
Daewoong Pharmaceutical
Market Cap: ₩1.4t
Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.
A069620
₩119,700.00
7D
0.7%
1Y
-27.0%
Perrigo
Market Cap: US$1.4b
Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.
PRGO
US$10.47
7D
3.2%
1Y
-62.8%
ARS Pharmaceuticals
Market Cap: US$639.5m
A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally.
SPRY
US$6.36
7D
-16.4%
1Y
-63.8%
Vanda Pharmaceuticals
Market Cap: US$319.9m
A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.
VNDA
US$5.48
7D
-6.3%
1Y
16.3%
Protara Therapeutics
Market Cap: US$229.9m
A clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases.
TARA
US$4.09
7D
-0.7%
1Y
20.6%
ADMA Biologics
Market Cap: US$2.0b
A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.
ADMA
US$8.59
7D
-3.2%
1Y
-49.6%